NovaBay Pharmaceuticals shares are trading higher after the company announced it reached a definitive deal to sell its Avenova assets for $9.5 million.
Portfolio Pulse from Benzinga Newsdesk
NovaBay Pharmaceuticals' shares rose following the announcement of a definitive agreement to sell its Avenova assets for $9.5 million.
September 20, 2024 | 1:13 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
NovaBay Pharmaceuticals' stock price increased after the company announced a definitive agreement to sell its Avenova assets for $9.5 million.
The sale of Avenova assets for $9.5 million is a significant transaction for NovaBay Pharmaceuticals, likely improving its financial position and leading to a positive market reaction, as evidenced by the rise in share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100